Mechanisms of ageing and development · 2011 · Cell / animal study · PMID 21354439
Limitations: Related construct only: MGF-E or full-length MGF; not clinical evidence for PEG-MGF.
Explore the library
Preclinical evidencePegylated MGF-related research construct
PEG-MGF
PEG-MGF refers to pegylated MGF-related research constructs. The source literature also discusses non-pegylated MGF-E and full-length MGF, which are not equivalent preparations.
Also indexed as: Pegylated Mechano Growth Factor
A clear starting point
PEG-MGF refers to pegylated MGF-related research constructs. The source literature also discusses non-pegylated MGF-E and full-length MGF, which are not equivalent preparations.
Systems mapping shows biological relevance, not a treatment recommendation or a patient CPI score.
No validated chemical structure is displayed in this edition.
How it works
IGF-1 / MGF signaling
PEG-MGF refers to pegylated MGF-related research constructs. The source literature also discusses non-pegylated MGF-E and full-length MGF, which are not equivalent preparations.
- Targets & processes
- IGF-1 / MGF signaling
- Systems & tissues
- See the pathway description; category links describe research relevance, not demonstrated treatment effects.
What does the evidence show?
Muscle progenitor-cell and growth-factor biology.
What this does not establish
The cited papers concern MGF-E peptide in cells and analytical characterization of full-length MGF—not clinical testing of PEG-MGF.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2014 · Analytical study · PMID 25466910
Limitations: Related construct only: MGF-E or full-length MGF; not clinical evidence for PEG-MGF.
Citation metadata from PubMed, a service of the U.S. National Library of Medicine, NIH. A citation match is not a guarantee of study quality. Abstracts are not full-text reviews.
Safety is a separate question
Human safety of PEG-MGF is not established. FDA identifies potential immunogenicity and no identified human exposure data for nominated drug products.
Contraindications & cautions
Not an exhaustive contraindication review. Human safety of PEG-MGF is not established. FDA identifies potential immunogenicity and no identified human exposure data for nominated drug products.
Medication & supplement interactions
Interaction information is incomplete. Human safety of PEG-MGF is not established. FDA identifies potential immunogenicity and no identified human exposure data for nominated drug products.
Regulatory status · United States
Not FDA-approved. No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Read the official sourceThis is not an exhaustive safety list. Regulatory status varies by jurisdiction and product; investigational use is not approval.
Make the science interactive
A dedicated lesson has not been published for this ingredient yet. Explore the cited profile or ask the instructor.
Your scientific classroom
Ask the IW Science Instructor
Basic level · Published sources only · AI evidence check
Ask about general science. Do not enter names, personal health details or medication lists. This is not a clinical consultation. Discussion stays in this browser’s private learning session for up to 90 days.
All medications and therapies discussed are for educational purposes only. Prescriptions are determined independently by the licensed clinician following a medical evaluation. There is no guarantee that any medication or peptide will be prescribed.
IW Interactive Learning Engine · Adapted from stable OpenMAIC v1.2.1. Open-source license
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.